-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FE3Yq4t2EMG+cROq+KKkHw9eePlTuhVx3vE6oBuEh5Be4GaqYanHt31cyahWnfA0 WyeeLqqtV7BFvO9KEqMdrQ== 0000890163-07-000459.txt : 20070726 0000890163-07-000459.hdr.sgml : 20070726 20070726170746 ACCESSION NUMBER: 0000890163-07-000459 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070725 FILED AS OF DATE: 20070726 DATE AS OF CHANGE: 20070726 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PIPEX PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: 734-332-7800 MAIL ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970730 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19940606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KANZER STEVE H CENTRAL INDEX KEY: 0001076653 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12584 FILM NUMBER: 071003888 BUSINESS ADDRESS: STREET 1: 210 CENTRAL PARK SOUTH CITY: NEW YORK STATE: NY ZIP: 10019 4 1 s11-7573_ex.xml X0202 4 2007-07-25 0 0000894158 PIPEX PHARMACEUTICALS, INC. PP 0001076653 KANZER STEVE H C/O PIPEX 3930 VARSITY DRIVE ANN ARBOR MI 48108 1 1 1 0 CEO Common Stock 2007-07-25 4 P 0 5000 7.42 A 315946 D Common Stock 2007-07-25 4 P 0 200 7.16 A 316146 D Common Stock 2007-07-25 4 P 0 2100 7.15 A 318246 D Common Stock 2007-07-25 4 P 0 2000 7.14 A 320246 D Common Stock 2007-07-25 4 P 0 5000 7.0908 A 325246 D Common Stock 2006-10-31 4 P 0 7086379 A 7086379 I Accredited Venture Capital, LLC Warrants 2.22 2006-10-31 4 A 0 832606 0 A 2006-10-31 2011-10-30 Common Stock 832606 832606 I Accredited Venture Capital, LLC Warrants 3.30 2007-01-05 4 A 0 7651 0 A 2007-01-05 2015-05-30 Common Stock 7651 7651 I Accredited Venture Capital, LLC Warrants 2.22 2006-11-28 4 A 0 373639 0 A 2006-11-28 2016-11-27 Common Stock 373369 373369 I Accredited Venture Capital, LLC Stock Options 2.01 2006-10-31 4 A 0 271058 0 A 2016-10-30 Common Stock 271058 271058 D Received in exchange for shares of Pipex Therapeutics, Inc. common stock upon the October 31, 2006 merger of Pipex Therapeutics, Inc. and a wholly owned subsidiary of the Registrant. Mr. Kanzer is the managing member of Pharmainvestors, LLC, the managing member of Accredited Venture Capital, LLC. Received in exchange for warrants of Pipex Therapeutics, Inc. upon the October 31, 2006 merger of Pipex Therapeutics, Inc. and a wholly owned subsidiary of the Registrant. Mr. Kanzer is the managing member of Pharmainvestors, LLC, the managing member of Accredited Venture Capital, LLC. Received in exchange for warrants of Effective Pharmaceuticals, Inc. upon the January 5, 2007 merger of Effective Pharmaceuticals, Inc. and a wholly owned subsidiary of the Registrant. Mr. Kanzer is the managing member of Pharmainvestors, LLC, the managing member of Accredited Venture Capital, LLC. Received in connection with placement agent services performed on behalf of Pipex Pharmaceuticals, Inc. Mr. Kanzer is the managing member of Pharmainvestors, LLC, the managing member of Accredited Venture Capital, LLC. One third of these stock options vested on the grant date and the remaining options will vest in equal installments on the first and second anniversaries of the grant date. Received in exchange for options of Pipex Therapeutics, Inc. upon the October 31, 2006 merger of Pipex Therapeutics, Inc. and a wholly owned subsidiary of the Registrant. /s/ Steve H. Kanzer 2007-07-26 -----END PRIVACY-ENHANCED MESSAGE-----